Resources
About Us
Home Report
Store
Whole Genome Sequencing Market
Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Library Preparation, DNA Extraction) Sequencing Type (Large, Small, Phased), Technology (SBS, SMRT, Nanopore, Nanoball) Application, End User – Global Forecast to 2031
Report ID:MRHC - 1041386 Pages: 312 Oct-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Global Whole Genome Sequencing Market is projected to reach $7.17 billion by 2031 at a CAGR of 15.2% from 2024 to 2031.
Whole Genome Sequencing Market Size & Forecast
The growth of this market can be attributed to declining costs of sequencing, the increasing prevalence of cancer & genetic disorders, the growing utilization of whole genome sequencing in disease diagnostics & precision medicine, increasing pharmaceutical R&D expenditures, improvements in regulatory & reimbursement scenarios for whole genome sequencing, rising healthcare expenditures, increasing funding for research activities, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, and government initiatives promoting the use of sequencing in clinical & research applications.
Furthermore, increasing applications of whole genome sequencing, government support for large-scale genomic sequencing projects, and emerging economies are expected to offer significant market growth opportunities.
Whole Genome Sequencing Market Growth Drivers
Increasing Prevalence of Cancer & Genetic Disorders
Whole-genome sequencing is frequently conducted in clinical settings, particularly for genetic diseases and chronic diseases like cancer. In the case of rare genetic diseases where no specific mutations have been observed using other molecular tests, advanced sequencing technologies are used for whole-genome sequencing. The global burden of genetic diseases and cancer is increasing. For instance,
- According to Global Genes, there are more than 10,000 distinct types of genetic and rare diseases. and 10 in 8 rare diseases are genetic.
- According to WHO report of February 2023, approximately 240,000 newborns die within 28 days and death of 170,000 children of age between 1 month and 5 years causes due to congenital disorders in the world.
- According to World Economic Forum (Switzerland) around 21 million people in China are suffering from rare disease.
- According to National Institutes of Health (NIH) around 20 million people in the world are suffering from sickle cell disease and 100,000 people in U.S. are affected by sickle cell disease.
- According to the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO), cancer incidence is expected to increase from 26.9 million in 2022 to 39.5 million in 2040. Moreover, mortalities due to cancer are estimated to increase from 9.7 million in 2022 to 35 million in 2050. Nearly 70% of the total deaths due to cancer occur in low and middle-income countries.
Thus, increasing prevalence of cancer genetic disorders is increasing the demand for diagnosis of genetic disorders which in turn is expected to drive the growth of whole genome sequencing market.
Advantages of Whole Genome Sequencing Such as High-Resolution, and Base-By-Base View of The Genome.
Whole Genome sequencing helps in capturing large and small variants in the genome and assists in analysis of individuals entire genome. High resolution of whole genome sequencing helps in identification of variations in the genome including translocations and copy number variations which makes it a powerful tool for studying genetic basis of various health conditions and diseases. Furthermore, whole genome sequencing is commonly used in sequencing the entire human genome but with the advent of next generation sequencing technology it can now be used for sequencing several species which includes plants, livestock, or diseases related to microorganism.
Base by base view offered by whole genome sequencing further helps in the detection of structural rearrangements, which allows the detection of variants in both coding and non-coding region, as interpretation of non-coding variants is difficult in conventional sequencing methods. Thus, advantages offered by whole genome sequencing increases its adoption in clinical settings driving the growth of whole genome sequencing market.
Whole Genome Sequencing Market Opportunity
Government Initiatives Supporting Large Scale Genomic Sequencing Projects
The availability of advanced sequencing technologies has lowered sequencing costs and significantly reduced the time required for genome sequencing. With the availability of safe and accurate genetic tests governments around the world aim to promote their use for better healthcare management by investing in genomic research. For instance,
- According to a report of February 2024 by Commonwealth of Australia, the Genomics Health Futures Mission invested USD 500.1 million in genomic research. This investment aims to deliver better testing, diagnostics, and treatment.
- In October 2023, Government of Canada invest USD 15 million for creating a Pan-Canadian Genome Library which allows easier sharing of genomic data across the country.
- In December 2022, Government Of U.K invested USD 217 million for boosting genomic research.
Thus, such initiatives are expected to support the growth of genomic research which is further expected to offer significant opportunities for the growth of the whole genome sequencing market.
Increasing Applications of Whole Genome Sequencing
Whole genome sequencing allows close analysis of gene mutations for diagnosis of disease and can be opted in critical situations where rapid diagnosis is important. Whole genome sequencing can be used to discover an original diagnosis of some unexplained conditions including intellectual disability, brain abnormalities, developmental issues such as delays in walking or talking, hearing or vision problems, severe skeletal abnormalities, immune deficiencies and others. Furthermore, increasing prevalence of genetic diseases in infants have increased the demand for prenatal screening, for preventing birth defects and whole genome sequencing shows an ability in detection of aneuploidies, microdeletions, which helps in reducing birth defects.
Whole Genome Sequencing Market Analysis: Key Findings
By Offering: In 2024, the Consumables Segment to Dominate the Whole Genome Sequencing Market
Based on offering, the whole genome sequencing market is segmented into consumables, sequencing instruments, software, and services. In 2024, the consumables segment is expected to account for the largest share of 70.1% of the whole genome sequencing market. The largest share of the segment is attributed to the recurring use of consumables, continuous advancements in reagents and target enrichment protocols and associated consumables, the increasing applications of whole genome sequencing in clinical settings driving the demand for consumables, Additionally, many companies are focusing on organic and inorganic strategies to enhance their consumable offerings which is contributing to the largest share of the segment.
By Sequencing Type: In 2024, the Large whole-genome sequencing Segment to Dominate the Whole Genome Sequencing Market
Based on sequencing type, the whole genome sequencing market is segmented into large whole-genome sequencing, small whole-genome sequencing, human whole-genome sequencing¸, and other whole-genome sequencing types. In 2024, the large whole genome sequencing segment is expected to account for the largest share of 76.7% of the whole genome sequencing market. Largest share of the segment is attributed to factors including large whole genome sequencing provides high resolution and base by base view of the genome, helps in sequencing large genome for providing population level studies. Furthermore whole genome sequencing is more often used for tumor analysis, investigation of disease cause, selection of animals and plants for breeding and identification of common genetic variations which is contributing to the largest share of the segment.
By Technology: In 2024, the Sequencing by Synthesis Segment to Dominate the whole genome Sequencing Market
Based on technology, the whole genome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing (SMRT), nanopore sequencing, DNA nanoball (DNB) sequencing. In 2024, the sequencing by synthesis segment is expected to account for the largest share of 56.5% of the whole genome sequencing market. The largest share of the segment is attributed to wide adoption of sequencing by synthesis technology, high accuracy offered by the technology it supports both paired-end and single-read libraries offers high resolution genome sequencing are the factors contributing to the largest share of the segment.
By Application: In 2024, the Research and Other Applications Segment to Dominate the Whole Genome Sequencing Market
Based on application, the whole genome sequencing market is segmented into research applications and clinical applications. In 2024, the research applications segment is expected to account for the largest share of the whole genome sequencing market. The research applications segment is further sub segmented into drug discovery, agriculture & animal research, and other applications. The largest share of the segment is attributed to the factors including the increasing utilization of whole genome for identifying novel drug targets, increasing demand for gene-based medicines, growing investments in drug research and development activities, and increasing research programs for personalized medicine. Additionally, whole genome sequencing is widely used in the research space to identify specific genes and their sequences, which is involved in developing targeted medicines, food microbiology, microbiota analysis in the beverage industry, and environmental studies.
By End User: In 2024, the Pharmaceutical & Biotechnology Companies Segment to Dominate the Whole Genome Sequencing Market
Based on end user, the whole genome sequencing market is segmented into pharmaceutical & biotechnology companies, hospitals and diagnostic laboratories, academic institutes & research centers, and other end users. In 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the whole genome sequencing market. The largest market share of this segment is attributed to factors such as the increasing R&D spending by pharmaceutical & biotechnology companies and the rising incidence of genetic diseases which drive the adoption of whole genome sequencing among pharmaceutical & biotechnology companies and the extensive utilization of advanced sequencing products for cancer studies.
Geographical Analysis
In 2024, North America is expected to account for the largest share of 52.1% of the whole genome sequencing market. The large market share of this region is primarily attributed to the high research investments by pharmaceutical and biopharmaceutical companies, presence of leading whole genome sequencing providers in the region, high awareness of whole genome sequencing, favorable government initiatives for genomics research applications, growing applications of NGS-based research, declining cost of sequencing, high cancer prevalence, and favorable reimbursement scenario in the region.
Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 16.4% during the forecast period. Asia-Pacific is becoming an increasingly active market for healthcare product manufacturers & service providers due to the improving healthcare infrastructure in the region. Asia-Pacific’s growing population is the key factor driving the region’s healthcare and pharmaceutical sectors, drawing a lot of investments from market players and government organizations. China, Japan, India, and Singapore aim to become competitive in the global biotech market, paving the way for many research and development activities in next-generation sequencing market. Such factors are supporting the fastest growth rate of the region.
Whole Genome Sequencing Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2021–2024). The key players operating in the whole genome sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K),MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China)
Whole Genome Sequencing Industry Overview: Latest Developments from Key Industry Players
- In May 2024, QIAGEN N.V. (Netherland) launched QIAseq Multimodal DNA/RNA Library Kit. The kit enables the preparation of RNA and DNA libraries for NGS, which includes whole transcriptome sequencing (WTS) and whole genome sequencing (WGS).
- In November 2023, QIAGEN N.V. (Netherland) launched a research workflow that includes high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis.
- In October 2023, Pacific Biosciences of California Inc. (U.S.) launched the Pacific Biosciences of California WGS variant pipeline. It is a complete, standardized computational method for HiFi Whole Genome Sequencing (WGS) data analysis.
- In March 2023, Illumina, Inc. (U.S.) launched Connected Insights, a cloud-based software for tertiary analysis of clinical next-generation sequencing data, including somatic oncology applications, whole genome sequencing for rare
diseases, and reduced turnaround time of clinical reporting via integration of third-party knowledge bases.
- In July 2022, Beijing Genomics Institute (BGI) (China), BGI Genomics partnered with the Serbian Genome Sequencing and Bioinformatics Center to enhance and develop the center's whole exome sequencing (WES), whole genome sequencing (WGS), and genomic analysis capabilities.
Whole Genome Sequencing Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
312 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
15.2% |
|
Estimated Market Size (Value) |
$7.17 billion by 2031 |
|
Segments Covered |
by Offering
by Sequencing Type
by Technology
by Application
by End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K), MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China) |
Key questions answered in the whole genome sequencing market report:
The global whole genome sequencing market report covers the qualitative analysis and market sizing of offering, sequencing type, technology, application, and end user. This report involves the analysis of various segments of whole genome sequencing at the regional and country level. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and Porter’s five forces analysis.
The global whole genome sequencing market is projected to reach $7.17 billion by 2031 at a CAGR of 15.2% from 2024 to 2031.
Among all the offerings studied, in this report in 2024, the consumables segment is expected to account for the largest share of the whole genome sequencing market. The largest share of this segment is attributed to advancements in kits and reagents, increasing prevalence of genetic disease, rising healthcare expenditure and declining sequencing cost.
Among all the technologies studied in this report, in 2024, the sequencing by synthesis segment is expected to account for the largest share of the whole genome sequencing market. The sequencing by synthesis technology offers long-insert paired-end reads for de novo sequencing and sequence assembly, it supports both paired end and single read libraries. Furthermore, its cost effectiveness, and high resolution genome sequencing increases the adoption of the sequencing by synthesis technology contributing to the largest share of the segment.
The growth of this market can be attributed to increasing prevalence of genetic disorders, rising healthcare expenditure, declining cost of sequencing, increasing pharmaceutical R&D expenditures, expanding clinical applications of whole genome sequencing, technological advancements in sequencing procedures, advantages of whole genome sequencing such as high-resolution, and base-by-base view of the genome.
Furthermore, government initiatives supporting large scale genomic sequencing projects, rising adoption of bioinformatics and genomic data management solutions, increasing number of whole genome sequencing projects are expected to offer significant market growth opportunities.
The key players operating in the whole genome sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K), MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China)
The countries like China and India are projected to offer significant growth opportunities for the vendors in this market. Growing population is the key factor driving the region’s healthcare and pharmaceutical sectors, rising prevalence of genetic disorders, increasing government initiatives and funding supporting genomic research, and improving healthcare infrastructure in the region are the factors which are expected to contribute to offer significant growth opportunities.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency And Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Market Share Analysis
2.3.3. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Pricing Analysis
4.4. Technology Trends
4.4.1. Emerging Sequencing Companies’ Focus on Improving Technologies and Reducing Costs
4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
4.4.1.2. Ultima Genomics, Inc. (U.S.)
4.4.1.3. Element Biosciences (U.S.)
4.4.2. Key Market Players’ Emphasis on Portable and Real-Time Sequencing Technologies
4.5. Regulatory Analysis
4.5.1. North America
4.5.1.1. U.S.
4.5.2. Europe
4.5.3. Asia-Pacific
4.5.4. Latin America
4.5.5. Middle East
4.6. Porter’s Five Forces Analysis
5. Whole Genome Sequencing Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Consumables
5.2.1.1. Library Preparation & Target Enrichment Consumables
5.2.1.2. Nucleic Acid Extraction & Amplification Consumables
5.2.1.3. Quality Control Consumables
5.2.1.4. Other Kits & Reagents
5.2.2. Other Consumables
5.3. Instruments
5.4. Software
5.5. Services
6. Whole Genome Sequencing Market Assessment—by Sequencing Type
6.1. Overview
6.2. Large Whole-Genome Sequencing
6.3. Small Whole-Genome Sequencing
6.4. Phased Sequencing
6.5. Other Whole-Genome Sequencing Types
7. Whole Genome Sequencing Market Assessment—by Application
7.1. Overview
7.2. Research & Other Applications
7.2.1. Drug Discovery
7.2.2. Agricultural & Animal Research
7.2.3. Other Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Other Clinical Applications
8. Whole Genome Sequencing Market Assessment—by Technology
8.1. Overview
8.2. Sequencing by Synthesis (SBS)
8.3. Ion Semiconductor Sequencing
8.4. Single-Molecule Real-Time Sequencing
8.5. DNA Nanoball Sequencing
8.6. Other Whole Genome Sequencing Technologies
9. Whole Genome Sequencing Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Whole Genome Sequencing Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis (2023)
11.5.1. Illumina, Inc. (U.S.)
11.5.2. Thermo Fisher Scientific Inc. (U.S.)
11.5.3. MGI Tech Co., Ltd. (China)
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
12.1. Illumina, Inc. (U.S.)
12.2. Thermo Fisher Scientific Inc.
12.3. F. Hoffmann-La Roche Ltd
12.4. QIAGEN N.V.
12.5. Agilent Technologies, Inc.
12.6. Revvity, Inc.
12.7. Pacific Biosciences of California Inc.
12.8. Danaher Corporation
12.9. Oxford Nanopore Technologies Plc.
12.10. MGI Tech Co., Ltd.
(Note: SWOT analyses of the top 5 companies will be provided.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Number of New Cancer Cases, by Type, 2022 Vs. 2040
Table 2 Common Genetic Disorders: Rates of Occurrence
Table 4 Major Genome Sequencing Projects, by Country
Table 5 Health Expenditure, by Country, 2020–2022 (USD)
Table 6 Whole Genome Sequencing Kits & Reagents: Pricing
Table 7 Whole Genome Sequencing Instruments: Product Description & Pricing
Table 9 Ug 100 Specifications
Table 10 Aviti Specifications
Table 11 Regulatory Authorities Governing In Vitro Diagnostics, by Country/Region
Table 12 Global Whole Genome Sequencing Market, by offering, 2022–2031 (USD Million)
Table 13 Global Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 14 Global Whole Genome Sequencing Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 16 Global Sample Preparation Consumables Market, by Country/Region, 2022-2031 (USD Million)
Table 17 Global Library Preparation & Target Enrichment Consumables Market, by Country/Region, 2022-2031 (USD Million)
Table 18 Global Nucleic Acid Extraction & Amplification Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Quality Control Consumables Market, by Country/Region, 2022-2031 (USD Million)
Table 20 Global Other Kits & Reagents Market, by Country/Region, 2022-2031” (USD Million)
Table 21 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
Table 22 Some of The Companies offering NGS Instruments for Whole Genome Sequencing are as Follows:
Table 23 Global Whole Genome Sequencing Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Key Players offering DNA Sequencing Software
Table 25 Global Whole Genome Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
Table 26 Key Players offering Instrument-Related Services
Table 27 Global Whole Genome Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
Table 28 Global Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
Table 29 Global Large Whole Genome Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Small Whole Genome Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Phased Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Other Whole Genome Sequencing Types Market, by Country/ Region, 2022–2031 (USD Million)
Table 33 Global Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
Table 34 Global Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 35 Global Whole Genome Sequencing Market for Research & Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Whole Genome Sequencing Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Whole Genome Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Whole Genome Sequencing Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 39 Global Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 40 Global Whole Genome Sequencing Market for Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 41 Global Whole Genome Sequencing Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 42 Global Whole Genome Sequencing Market for Reproductive Health, by Country/Region, 2022–2031 (USD Million)
Table 43 HIV Prevalence Among Adults, by Region (2020 Vs. 2022) (In Million)
Table 44 Global Whole Genome Sequencing Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 45 Global Whole Genome Sequencing Market for Other Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 46 Global Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
Table 47 Global Whole Genome Sequencing Market for Sequencing by Synthesis, by Country/Region, 2022–2031 (USD Million)
Table 48 Global Whole Genome Sequencing Market for Ion Semiconductor Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 49 Global Whole Genome Sequencing Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 50 Global Whole Genome Sequencing Market for DNA Nanoball Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 51 Global Whole Genome Sequencing Marker for Other Whole Genome Sequencing Technologies, by Country/Region, 2022–2031 (USD Million)
Table 52 Global Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
Table 53 Global Whole Genome Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 54 Global Whole Genome Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 55 Global Whole Genome Sequencing Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 56 Global Whole Genome Sequencing Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 57 Global Whole Genome Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 58 North America: Whole Genome Sequencing Market, by Country, 2022–2031 (USD Million)
Table 59 North America: Whole Genome Sequencing Market, by offering, 2022–2031 (USD Million)
Table 60 North America: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 61 North America: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 62 North America: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 63 North America: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 64 North America: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 65 North America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 66 North America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 67 North America: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 68 U.S.: Key Macroindicators & Microindicators
Table 69 U.S.: Whole Genome Sequencing Market, by offering, 2022–2031 (USD Million)
Table 70 U.S.: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 71 U.S.: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 72 U.S.: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 73 U.S.: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 74 U.S.: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 75 U.S.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 76 U.S.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 77 U.S.: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 78 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments And Genome Canada Contributions, Are As Follows:
Table 79 Canada: Key Macroindicators & Microindicators
Table 80 Canada: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 81 Canada: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 82 Canada: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 83 Canada: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 84 Canada: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 85 Canada: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 86 Canada: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 87 Canada: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 88 Canada: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 89 Europe: Whole Genome Sequencing Market, by Country/Region, 2022–2031(USD Million)
Table 90 Europe: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 91 Europe: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 92 Europe: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 93 Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 94 Europe: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 95 Europe: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 96 Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 97 Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 98 Europe: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 99 Germany: Key Macroindicators & Microindicators
Table 100 Germany: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 101 Germany: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 102 Germany: Sample Preparation Consumables Market, by Type, 2022–2031(USD Million)
Table 103 Germany: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 104 Germany: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 105 Germany: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 106 Germany: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 107 Germany: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 108 Germany: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 109 France: Key Macroindicators & Microindicators
Table 110 France: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 111 France: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 112 France: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 113 France: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 114 France: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 115 France: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 116 France: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 117 France: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 118 France: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 119 U.K.: Key Macroindicators & Microindicators
Table 120 U.K.: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 121 U.K.: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 122 U.K.: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 123 U.K.: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 124 U.K.: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 125 U.K.: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 126 U.K.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 127 U.K.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 128 U.K.: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 129 Italy: Key Macroindicators & Microindicators
Table 130 Italy: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 131 Italy: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 132 Italy: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 133 Italy: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 134 Italy: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 135 Italy: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 136 Italy: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 137 Italy: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 138 Italy: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 139 Spain: Key Macroindicators & Microindicators
Table 140 Spain: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 141 Spain: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 142 Spain: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 143 Spain: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 144 Spain: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 145 Spain: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 146 Spain: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 147 Spain: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 148 Spain: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 149 Number of Sequences in Each Phase And Other Related Sequencing Information In Switzerland
Table 150 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
Table 151 Rest of Europe: Whole Genome Sequencing Market, by Offering, 2022–2031(USD Million)
Table 152 Rest of Europe: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 153 Rest of Europe: Sample Preparation Consumables Market, by Type, 2022–2031(USD Million)
Table 154 Rest of Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 155 Rest of Europe: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 156 Rest of Europe: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 157 Rest of Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 158 Rest of Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 159 Rest of Europe: Whole Genome Sequencing Market, by End User, 2022–2031(USD Million)
Table 160 Asia-Pacific: Whole Genome Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 161 Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022–2031(USD Million)
Table 162 Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 163 Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022–2031(USD Million)
Table 164 Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 165 Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 166 Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 167 Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 168 Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 169 Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022–2031(USD Million)
Table 170 China: Key Macroindicators & Microindicators
Table 171 China: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 172 China: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 173 China: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 174 China: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 175 China: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 176 China: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 177 China: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 178 China: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 179 China: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 180 Japan: Key Macroindicators & Microindicators
Table 181 Japan: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 182 Japan: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 183 Japan: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 184 Japan: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 185 Japan: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 186 Japan: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 187 Japan: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 188 Japan: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 189 Japan: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 190 India: Key Macroindicators & Microindicators
Table 191 India: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 192 India: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 193 India: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 194 India: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 195 India: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 196 India: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 197 India: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 198 India: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 199 India: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 200 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
Table 201 Projects Funded by Australian Genomics, As Part of Its Genomic Implementation Projects In 2022 And 2023
Table 202 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 203 Rest of Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 204 Rest of Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 205 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 206 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 207 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 208 Rest of Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 209 Rest of Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 210 Rest of Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 211 Latin America: Whole Genome Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 212 Latin America: Whole Genome Sequencing Market, by Offering, 2022–2031(USD Million)
Table 213 Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 214 Latin America: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 215 Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 216 Latin America: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 217 Latin America: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 218 Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 219 Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 220 Latin America: Whole Genome Sequencing Market, by End User, 2022–2031(USD Million)
Table 221 Brazil: Key Macroindicators & Microindicators
Table 222 Brazil: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 223 Brazil: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 224 Brazil: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 225 Brazil: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 226 Brazil: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 227 Brazil: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 228 Brazil: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 229 Brazil: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 230 Brazil: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 231 Mexico: Key Macroindicators & Microindicators
Table 232 Mexico: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 233 Mexico: Whole Genome Sequencing Consumables Market, by Type, 2022–2031(USD Million)
Table 234 Mexico: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 235 Mexico: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031(USD Million)
Table 236 Mexico: Whole Genome Sequencing Market, by Technology, 2022–2031(USD Million)
Table 237 Mexico: Whole Genome Sequencing Market, by Application, 2022–2031(USD Million)
Table 238 Mexico: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 239 Mexico: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 240 Mexico: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 241 Rest of Latin America: Number of New Cancer Cases, by Country, 2022 Vs. 2030
Table 242 Rest of Latin America: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 243 Rest of Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 244 Rest of Latin America: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 245 Rest of Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 246 Rest of Latin America: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 247 Rest of Latin America: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 248 Rest of Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 249 Rest of Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 250 Rest of Latin America: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
Table 251 Middle East & Africa: Whole Genome Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 252 Middle East & Africa: Whole Genome Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 253 Middle East & Africa: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 254 Middle East & Africa: Whole Genome Sequencing Market, by Sequencing Type, 2022–2031 (USD Million)
Table 255 Middle East & Africa: Whole Genome Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 256 Middle East & Africa: Whole Genome Sequencing Market, by Application, 2022–2031 (USD Million)
Table 257 Middle East & Africa: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 258 Middle East & Africa: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 259 Middle East & Africa: Whole Genome Sequencing Market, by End User, 2022–2031 (USD Million)
List of Figures
Figure 1 Key Stakeholders
Figure 2 Research Process
Figure 3 Secondary Sources Referenced for This Study
Figure 4 Primary Research Techniques
Figure 5 Key Executives Interviewed
Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 7 Market Sizing and Growth forecast Approach
Figure 8 Global Whole Genome Sequencing Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 9 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
Figure 10 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 11 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 12 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 13 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 14 Global Whole Genome Sequencing Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2024–2031)
Figure 15 Global Share of Cancer Cases, by Region, 2022 Vs. 2040 (%)
Figure 16 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2020 Vs. 2021 (USD Million)
Figure 17 Global Pharmaceutical R&D Expenditure, 2014–2028 (USD Billion)
Figure 18 Percentage of Approved Personalized Medicines: Cancer Vs. Rare Diseases Vs. Other Diseases, 2022
Figure 19 USFDA Regulatory Pathways for IVD Kits
Figure 20 Eu Regulatory Pathway - IVDR 2017/746
Figure 21 China: Medical Device Classification and Premarket Requirements for IVD Products
Figure 22 Porter's Five forces Analysis
Figure 23 Global Whole Genome Sequencing Market, by Offering, 2022 Vs. 2031 (USD Million)
Figure 24 Steps of Sample Preparation In A Typical Next-Generation Sequencing Workflow
Figure 25 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
Figure 26 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 27 U.S.: New Molecular Entity (NME) Approvals
Figure 28 Estimated Number of New Cancer Cases (Million)
Figure 29 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 30 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 31 Global Pharmaceutical R&D Spending, 2014-2026 (USD Million)
Figure 32 Pharmaceutical Spending In 2021 Vs. 2022 (In % of Health Spending)
Figure 33 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 34 North America: Whole Genome Sequencing Market Snapshot
Figure 35 U.S.: Pharmaceutical R&D Expenditure, 2014–2022 (USD Billion)
Figure 36 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
Figure 37 Research Funding Supported by The Canadian Genomics Enterprise, 2022–2023 (%)
Figure 38 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
Figure 39 Europe: Pharmaceutical Industry R&D Expenditure, 2000–2022 (USD Million)
Figure 40 Europe: Whole Genome Sequencing Market Snapshot
Figure 41 Italy: Number of Biotechnology Firms, 2014-2022
Figure 42 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
Figure 43 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
Figure 44 Asia-Pacific: Whole Genome Sequencing Market Snapshot
Figure 45 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
Figure 46 Japan: Number of New Molecular Entities Approved, 2014-2022
Figure 47 Latin America: Whole Genome Sequencing Market Snapshot
Figure 48 Key Growth Strategies Adopted by Leading Players, 2021– 2024
Figure 49 Global Whole Genome Sequencing Market: Competitive Benchmarking by Offering
Figure 50 Global Whole Genome Sequencing Market: Competitive Benchmarking, by Region
Figure 51 Competitive Dashboard: Global Whole Genome Sequencing Market
Figure 52 Global Whole Genome Sequencing Market Share Analysis, by Key Players, 2023 (%)
Figure 53 Illumina, Inc.: Financial Snapshot (2023)
Figure 54 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 55 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
Figure 56 QIAGEN N.V: Financial Snapshot (2023)
Figure 57 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 58 Revvity, Inc.: Financial Snapshot (2023)
Figure 59 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
Figure 60 Danaher Corporation: Financial Snapshot (2023)
Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
Figure 62 MGI Tech Co., Ltd.: Financial Snapshot (2023)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
DNA Sequencing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
Sequencing Kits Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
